Meruvax II and Perflutren lipid microsphere Intravenous
Determining the interaction of Meruvax II and Perflutren lipid microsphere Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: rubella virus vaccine
Brand name:
Synonyms: Meruvax II (Subcutaneous)
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Meruvax II-Perflutren Lipid Microspheres
- Meruvax II-Perflutren Protein Type A
- Meruvax II-Perflutren protein type a microsphere Intravenous
- Meruvax II-Perforomist
- Meruvax II-Perforomist, Symbicort
- Meruvax II-Pergolide
- Perflutren lipid microsphere Intravenous-Mesalamine
- Perflutren lipid microsphere Intravenous-Mesalamine Controlled-Release Capsules
- Perflutren lipid microsphere Intravenous-Mesalamine Delayed Release Tablets
- Perflutren lipid microsphere Intravenous-Mesalamine Long-Acting Capsules (Apriso)
- Perflutren lipid microsphere Intravenous-Mesalamine Long-Acting Capsules (Delzicol)
- Perflutren lipid microsphere Intravenous-Mesalamine Long-Acting Capsules (Pentasa)